Form 4: TransMedics Group Executive Tamer Khayal Executes Stock Options and Sells Shares
SEC Form 4 Filing
Tamer Khayal, Chief Commercial Officer of TransMedics Group, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Tamer Khayal, Chief Commercial Officer of TransMedics Group, Inc. (TMDX), executed stock options and sold shares of common stock.
- The transactions occurred on April 8 and April 9, 2024.
- The stock options were exercised at prices of $16.14 and $38.46.
- Shares were sold at weighted average prices ranging from $90.00 to $91.17.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan established on September 6, 2023.
- Following these transactions, Khayal directly owns 25,185 shares of common stock and indirectly owns 14,776 shares through the Khayal Family 2021 Irrevocable Trust and 11,051 shares through the Tamer Ibrahim Ahmed Khayal Trust.
- Khayal also holds 61,368 stock options.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't convey any explicit positive or negative sentiment about the company's performance or future prospects.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a change in the company's outlook or performance.
Key Dates
| Date | Description |
|---|---|
| 09/06/2023 | Date of establishment of Rule 10b5-1 trading plan |
| 02/24/2021 | Vesting commencement date for some stock options |
| 04/08/2024 | Date of first reported transaction (option exercise and share sale) |
| 04/09/2024 | Date of subsequent reported transactions (option exercise and share sale) |
| 04/10/2024 | Date of Form 4 filing |
| 02/27/2030 | Expiration date for some stock options |
| 02/24/2031 | Expiration date for some stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.